Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 9/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 3/20 | 0.35 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18952965 | 0.90 | MMP13 (0.38) | MMP13SLC22A12NPBWR1MCHR1KDM5A | |
| SCHEMBL1982561 | 0.88 | AR (0.47) | MMP13SLC22A12AR | |
| SCHEMBL18952992 | 0.86 | MMP13 (0.39) | MMP13AR | |
| SCHEMBL12594113 | 0.86 | AR (0.38) | MMP13SLC22A12ARNPBWR1MCHR1 | |
| SCHEMBL18952955 | 0.86 | MMP13 (0.42) | MMP13SLC22A12AR | |
| SCHEMBL18952979 | 0.85 | MMP13 (0.41) | MMP13AR | |
| SCHEMBL18952954 | 0.83 | MMP13 (0.42) | MMP13SLC22A12ARHRH3 | |
| SCHEMBL15535817 | 0.82 | MMP13 (0.41) | MMP13SLC22A12AR | |
| SCHEMBL18952942 | 0.80 | GPR119 (0.40) | MMP13HRH3 | |
| SCHEMBL1980366 | 0.79 | AR (0.36) | MMP13SLC22A12ARNPBWR1MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2852588-A1 | HYDANTOIN DERIVATIVES AS KV3 INHIBITORS | Autifony Therapeutics Limited (GB) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013175211-A1 | HYDANTOIN DERIVATIVES AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LIMITED (GB) | 2013-11-28 | — | — | WO | disclosed |